---
title: "LIFETECH SCI to Acquire 96.46% of Starway Medical Tech via CB for RMB1.87B"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287571330.md"
description: "LIFETECH SCI will acquire 96.46% of Starway Medical Technology for RMB1.87 billion through convertible bonds. The bonds have a 3.5% interest rate and a three-year term, with an initial conversion price of HKD2.5 per share. This acquisition will make Starway a non-wholly owned subsidiary and Hillhouse Investment Management the largest shareholder of LIFETECH SCI."
datetime: "2026-05-26T02:33:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287571330.md)
  - [en](https://longbridge.com/en/news/287571330.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287571330.md)
generator: "portal-rs"
---

# LIFETECH SCI to Acquire 96.46% of Starway Medical Tech via CB for RMB1.87B

LIFETECH SCI (01302.HK) -0.280 (-12.121%) Short selling $14.04M; Ratio 5.746% announced that it will acquire approximately 96.46% equity interest in domestic congenital heart defect occluder manufacturer Starway Medical Technology from AUT-VII, a wholly owned subsidiary of Hillhouse Investment Management, at a consideration of approximately RMB1.8733 billion.

The consideration will be fully satisfied by the issuance of convertible bonds. The parties have entered into a legally binding framework agreement. Upon completion, Starway Medical Technology will become a non-wholly owned subsidiary of the Company.

The convertible bonds carry an interest rate of 3.5% per annum, payable quarterly in cash, with a term of three years. The initial conversion price is HKD2.5 per share, representing a premium of approximately 8.23% over the closing price of HKD2.31 last Friday (22nd). 

Upon full conversion, approximately 860 million new shares will be issued, representing about 15.66% of the enlarged share capital, making Hillhouse Investment Management the single largest shareholder of LIFETECH SCI.  
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-22 16:25.)

### Related Stocks

- [01302.HK](https://longbridge.com/en/quote/01302.HK.md)

## Related News & Research

- [LifeTech Scientific drops proposed Starway Equity acquisition after failing to reach terms](https://longbridge.com/en/news/293201934.md)
- [Fleury closes BRL 1.83 billion two-tranche unsecured debenture offering](https://longbridge.com/en/news/296838831.md)
- [SSY Group H1 FY26 net profit attributable to shareholders rises 13% to HK$320.32 million; revenue climbs 9.9% to HK$2.36 billion](https://longbridge.com/en/news/297041744.md)
- [China’s CXMT hits a DRAM production ceiling as global memory prices keep climbing](https://longbridge.com/en/news/296858852.md)
- [Eltel buys EWII street lighting business in Jutland](https://longbridge.com/en/news/297005499.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**